Carcinogenicity of human papillomaviruses.

By V. Cogliano, R. Baan, K. Straif, Y. Grosse, B. Secretan, F. El Ghissassi. The Lancet Oncology, 2005

700 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/74d86f1f0b1f82325c6c72934e9b61f5ef57b0bc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. M. Arbyn

In Oncology

1. M. Arbyn

Citations in the corpus

• 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. (2007, background): “It is also important to stress that testing should be restricted to high-risk (oncogenic) HPV types.(7,8)”
• European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document (2010, background): “Persistent infection with one of 13–16 oncogenic HPV types is now known to be a key prerequisite for development of cervical cancer [9, 10].”